A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bioequivalence
Interventions: DRUG: Doxorubicin Hydrochloride Liposome Injection
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.